ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
139.64
-0.90 (-0.64%)
At close: Apr 15, 2025, 4:00 PM
143.99
+4.35 (3.12%)
Pre-market: Apr 16, 2025, 4:53 AM EDT
ICU Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ICU Medical stock have an average target of 199.67, with a low estimate of 190 and a high estimate of 209. The average target predicts an increase of 42.99% from the current stock price of 139.64.
Analyst Consensus: Buy
* Price targets were last updated on Dec 11, 2024.
Analyst Ratings
The average analyst rating for ICU Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $200 | Hold → Strong Buy | Upgrades | $200 | +43.23% | Dec 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $198 → $209 | Buy | Maintains | $198 → $209 | +49.67% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| Keybanc | Keybanc | Buy Maintains $147 → $198 | Buy | Maintains | $147 → $198 | +41.79% | Oct 15, 2024 |
Financial Forecast
Revenue This Year
2.40B
from 2.38B
Increased by 0.84%
Revenue Next Year
2.47B
from 2.40B
Increased by 2.91%
EPS This Year
6.76
from -4.83
EPS Next Year
8.27
from 6.76
Increased by 22.26%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.5B | 2.6B | 2.7B | ||
| Avg | 2.4B | 2.5B | 2.6B | ||
| Low | 2.1B | 2.1B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.2% | 9.6% | 9.7% | ||
| Avg | 0.8% | 2.9% | 5.6% | ||
| Low | -11.6% | -12.1% | -0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.39 | 9.06 | 10.01 | ||
| Avg | 6.76 | 8.27 | 9.71 | ||
| Low | 5.29 | 6.37 | 9.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 34.0% | 21.0% | ||
| Avg | - | 22.3% | 17.4% | ||
| Low | - | -5.8% | 12.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.